Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma

PURPOSE: Proton magnetic resonance spectroscopy (MRS) of the brain can detect 2-hydroxyglutarate (2HG), the oncometabolite produced in neoplasms harboring a mutation in the gene coding for isocitrate dehydrogenase (IDH). We conducted a prospective longitudinal imaging study to determine whether quan...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Oncol
Päätekijät: Choi, Changho, Raisanen, Jack M., Ganji, Sandeep K., Zhang, Song, McNeil, Sarah S., An, Zhongxu, Madan, Akshay, Hatanpaa, Kimmo J., Vemireddy, Vamsidhara, Sheppard, Christie A., Oliver, Dwight, Hulsey, Keith M., Tiwari, Vivek, Mashimo, Tomoyuki, Battiste, James, Barnett, Samuel, Madden, Christopher J., Patel, Toral R., Pan, Edward, Malloy, Craig R., Mickey, Bruce E., Bachoo, Robert M., Maher, Elizabeth A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2016
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5477829/
https://ncbi.nlm.nih.gov/pubmed/28248126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.67.1222
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia